EP2079448 - IMPROVED RELEASE OF STATINS IN THE INTESTINE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.04.2013 Database last updated on 14.06.2024 | Most recent event Tooltip | 05.04.2013 | Application deemed to be withdrawn | published on 08.05.2013 [2013/19] | Applicant(s) | For all designated states Dexcel Pharma Technologies Ltd. P.O. Box 50 38100 Hadera / IL | [2009/30] | Inventor(s) | 01 /
PENHASI, Adel 53/15 Rabinovich Street 58671 Holon / IL | 02 /
GOMBERG, Maxim 420/19 Neve Jakov 97350 Jerusalem / IL | [2009/30] | Representative(s) | Straus, Alexander, et al Patentanwälte Becker, Kurig, Straus Bavariastrasse 7 80336 München / DE | [N/P] |
Former [2009/30] | Straus, Alexander, et al Patentanwälte Becker, Kurig, Straus Bavariastrasse 7 80336 München / DE | Application number, filing date | 07827194.7 | 09.10.2007 | [2009/30] | WO2007IL01220 | Priority number, date | US20060850255P | 10.10.2006 Original published format: US 850255 P | [2009/30] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008044236 | Date: | 17.04.2008 | Language: | EN | [2008/16] | Type: | A2 Application without search report | No.: | EP2079448 | Date: | 22.07.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.04.2008 takes the place of the publication of the European patent application. | [2009/30] | Search report(s) | International search report - published on: | EP | 26.06.2008 | Classification | IPC: | A61K9/20 | [2009/30] | CPC: |
A61K9/2886 (EP,US);
A61K9/2013 (EP,US);
A61K9/2018 (EP,US);
A61K9/2027 (EP,US);
A61K9/2054 (EP,US);
A61K9/282 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/30] | Title | German: | VERBESSERTE FREISETZUNG VON STATINEN IM DARM | [2009/30] | English: | IMPROVED RELEASE OF STATINS IN THE INTESTINE | [2009/30] | French: | LIBÉRATION AMÉLIORÉE DE STATINES DANS L'INTESTIN | [2009/30] | Entry into regional phase | 07.04.2009 | National basic fee paid | 07.04.2009 | Designation fee(s) paid | 07.04.2009 | Examination fee paid | Examination procedure | 07.04.2009 | Amendment by applicant (claims and/or description) | 07.04.2009 | Examination requested [2009/30] | 20.07.2009 | Despatch of a communication from the examining division (Time limit: M06) | 28.01.2010 | Reply to a communication from the examining division | 29.06.2012 | Despatch of a communication from the examining division (Time limit: M04) | 10.11.2012 | Application deemed to be withdrawn, date of legal effect [2013/19] | 19.12.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/19] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.07.2009 | Fees paid | Renewal fee | 26.10.2009 | Renewal fee patent year 03 | 12.10.2010 | Renewal fee patent year 04 | 25.10.2011 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.10.2012 | 06   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9930692 (ANDRX PHARMACEUTICALS INC [US]) [X] 1-57 * page 9, lines 3-19; example 1; claims 1-12 *; | [X]WO0134123 (ANDRX CORP [US], et al) [X] 1-57 * pages 16-17; example 1; table 1 *; | [X]WO0074655 (PERIO PROD LTD [IL], et al) [X] 1,3,8-10,17-47,49 * page 33; claims 1-19,35 *; | [X]EP1021171 (PERIO PROD LTD [IL]) [X] 1,3,8-10,17-47,49 * paragraphs [0093] , [0102]; claims 1,4,5,8 *; | [A]EP1191926 (ASTRAZENECA AB [SE]) [A] 1-57 * claims 1-18 *; | [A]WO9725979 (PERIO PROD LTD [IL]) [A] 1-57 * pages 38-40; claims 1-20 *; | [A]EP0210540 (FUJISAWA PHARMACEUTICAL CO [JP]) [A] 1-57 * column 1, lines 4-14; figure 1 * |